Emergent BioSolutions
EBS
#6672
Rank
HK$5.38 B
Marketcap
HK$100.98
Share price
-2.99%
Change (1 day)
31.27%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2025 (TTM): HK$10.97

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is HK$10.99. In 2024 the company made an earnings per share (EPS) of -HK$28.28 an increase over its 2023 EPS that were of -HK$115.97.

EPS history for Emergent BioSolutions from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$10.97-138.77%
2024-HK$28.28-75.61%
2023-HK$115.97232.21%
2022-HK$34.91-203.46%
2021HK$33.74-25.09%
2020HK$45.04445.28%
2019HK$8.26-15.2%
2018HK$9.74-35.9%
2017HK$15.1969.57%
2016HK$8.96-27.67%
2015HK$12.3965.63%
2014HK$7.4811.63%
2013HK$6.7032.31%
2012HK$5.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Merck
MRK
HK$59.17 438.57%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$3.27-70.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$28.02 155.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-HK$26.34-339.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.40 21.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.91-55.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
-HK$25.25-329.79%๐Ÿ‡บ๐Ÿ‡ธ USA